Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ida Skarping"'
Autor:
Ida Skarping
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: Although the diagnostic accuracy of 18F-fluorodeoxyglucose – positron emission tomography/computed tomography (18F-FDG-PET/CT) for breast cancer (BC) has been well studied, few studies have evaluated the impact of 18F-FDG-PE
Externí odkaz:
https://doaj.org/article/3025f17f35384d2a9a95d0986383e06c
Autor:
Ida Skarping, Julia Ellbrant, Looket Dihge, Mattias Ohlsson, Linnea Huss, Pär-Ola Bendahl, Lisa Rydén
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Surgical sentinel lymph node biopsy (SLNB) is routinely used to reliably stage axillary lymph nodes in early breast cancer (BC). However, SLNB may be associated with postoperative arm morbidities. For most patients with BC undergo
Externí odkaz:
https://doaj.org/article/5b95133ec0ea4882880637b2ce74f48f
Autor:
Malin Hjärtström, Looket Dihge, Pär-Ola Bendahl, Ida Skarping, Julia Ellbrant, Mattias Ohlsson, Lisa Rydén
Publikováno v:
JMIR Cancer, Vol 9, p e46474 (2023)
BackgroundMost patients diagnosed with breast cancer present with a node-negative disease. Sentinel lymph node biopsy (SLNB) is routinely used for axillary staging, leaving patients with healthy axillary lymph nodes without therapeutic effects but at
Externí odkaz:
https://doaj.org/article/f0b70b9b4b9a4c389dbf1c8a837b4f3b
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThe association between mammographic density (MD) and breast cancer (BC) recurrence and survival remains unclear. Patients receiving neoadjuvant chemotherapy (NACT) are in a vulnerable situation with the tumor within the breast during treatm
Externí odkaz:
https://doaj.org/article/0934dc02f4934be3bd43842624252284
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveTo implement artificial neural network (ANN) algorithms for noninvasive lymph node staging (NILS) to a decision support tool and facilitate the option to omit surgical axillary staging in breast cancer patients with low-risk of nodal metasta
Externí odkaz:
https://doaj.org/article/c98a87e64ab2456f975a0233e498924b
Autor:
Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen, Hanna Sartor, Per Hall, Sophia Zackrisson, Signe Borgquist
Publikováno v:
Breast, Vol 53, Iss , Pp 33-41 (2020)
Objectives: To assess if mammographic density (MD) changes during neoadjuvant breast cancer treatment and is predictive of a pathological complete response (pCR). Methods: We prospectively included 200 breast cancer patients assigned to neoadjuvant c
Externí odkaz:
https://doaj.org/article/a553cb26ae1f45268c33b7fc7fc7fb91
Autor:
Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson, Signe Borgquist
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients. Methods Data on all n
Externí odkaz:
https://doaj.org/article/3dc0f5e6211944bca7f06ccfb7f4ee8d
Autor:
Ida Skarping, Looket Dihge, Pär-Ola Bendahl, Linnea Huss, Julia Ellbrant, Mattias Ohlsson, Lisa Rydén
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 582 (2022)
Newly diagnosed breast cancer (BC) patients with clinical T1–T2 N0 disease undergo sentinel-lymph-node (SLN) biopsy, although most of them have a benign SLN. The pilot noninvasive lymph node staging (NILS) artificial neural network (ANN) model to p
Externí odkaz:
https://doaj.org/article/8e9f70718ed641c7a958ac3ea2c23b57
Autor:
Ida Skarping, Julia Ellbrant, Looket Dihge, Mattias Ohlsson, Linnea Huss, Pär-Ola Bendahl, Lisa Rydén
Background Surgical sentinel lymph node biopsy (SLNB) is routinely used to reliably stage axillary lymph nodes in early breast cancer (BC). However, SLNB may be associated with postoperative arm morbidities. For most patients with BC undergoing SLNB,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1da8889aeab209e052bdc685abf2cf2b
https://doi.org/10.21203/rs.3.rs-2686975/v1
https://doi.org/10.21203/rs.3.rs-2686975/v1
Publikováno v:
Skarping, I, Pedersen, S B, Förnvik, D, Zackrisson, S & Borgquist, S 2022, ' The association between body mass index and pathological complete response in neoadjuvant-treated breast cancer patients ', Acta Oncologica, vol. 61, no. 6, pp. 731-737 . https://doi.org/10.1080/0284186X.2022.2055976
Background: Obesity seems to be associated with a poorer response to adjuvant chemotherapy in breast cancer (BC); however, associations in the neoadjuvant chemotherapy (NACT) setting and according to menopausal status are less studied. This study aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70266d65fda132944b11598548aa0fa8
https://pure.au.dk/portal/da/publications/the-association-between-body-mass-index-and-pathological-complete-response-in-neoadjuvanttreated-breast-cancer-patients(9a74799b-bc8c-4ee6-87f0-f0a379704213).html
https://pure.au.dk/portal/da/publications/the-association-between-body-mass-index-and-pathological-complete-response-in-neoadjuvanttreated-breast-cancer-patients(9a74799b-bc8c-4ee6-87f0-f0a379704213).html